节点文献

近视防控用阿托品眼用制剂的研究进展

Research Progress of Atropine Ophthalmic Formulations for Myopia Prevention and Control

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张涛黄聪刘会文陆伟跃

【Author】 ZHANG Tao;HUANG Cong;LIU Huiwen;LU Weiyue;School of Pharmacy, Fudan University;Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd.;

【通讯作者】 陆伟跃;

【机构】 复旦大学药学院拨康视云生物医药科技(广州)有限公司

【摘要】 低浓度阿托品滴眼剂作为延缓青少年近视的眼用制剂,临床疗效已得到广泛认可,但已上市的硫酸阿托品水溶液型滴眼剂存在因pH值低而导致的眼刺激性、制剂稳定性差和患者依从性差等问题。该文对目前在研和在售的硫酸阿托品眼用制剂的处方和制备工艺进行了文献调研和总结,分析了各种改善硫酸阿托品眼用制剂稳定性和依从性的技术方案特点和优劣势,以期为阿托品眼用制剂的优化提供一定的参考。

【Abstract】 Low-concentration atropine eyedrops,an ophthalmic formulation for delaying myopia of adolescents,has been widely recognized due to its clinical therapeutic effects.However,the commercialized atropine sulfate eyedrops,ophthalmicaqueous solution,have many problems,such as eye irritation caused by low pH value of the aqueous solution,poorstability of the preparations and poor patient compliance.In this review,the formulations and preparation processes of atropinesulfate ophthalmic preparations currently under development and on the market are summarized,the characteristics,advantagesand disadvantages of various technical approaches for improving stability and compliance of atropine sulfate ophthalmic products are analyzed,hoping to provide some references for the optimization of atropine ophthalmic formulations.

【关键词】 阿托品近视眼用制剂滴眼剂研究进展
【Key words】 atropinemyopiaophthalmic formulationeyedropsresearch progress
  • 【文献出处】 中国医药工业杂志 ,Chinese Journal of Pharmaceuticals , 编辑部邮箱 ,2024年12期
  • 【分类号】R943
  • 【下载频次】62
节点文献中: 

本文链接的文献网络图示:

本文的引文网络